for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BUZZ-Valeant Pharma: To rename itself as Bausch Health, raises revenue outlook

** Canadian drugmaker’s U.S.-listed shares rise 5.73 pct at $19.20 in premarket trade

** VRX is fourth most actively traded across all U.S. exchanges in premarket trade; VRX one of the biggest pct gainers among NYSE-listed stocks

** Co raised its 2018 revenue forecast, and said it would change its name to Bausch Health Companies Inc

** Co to change its name and roll out a new corporate brand identity in July 2018; to trade under new ticker “BHC”

** Up to Monday’s close, stock had fallen ~13 pct this year (Reporting by Akankshita Mukhopadhyay in Bengaluru)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up